Implications for IABP Use in Shock: Lessons Learned From the Cardiogenic Shock Registry

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abiomed; NuPulseCV; Getinge; Boston Scientific Corporation</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Teleflex</li></ul>